Bausch + Lomb is acquiring Johnson & Johnson’s Blink line of eye drops. The deal comes as J&J exits the consumer business while Bausch + Lomb expands its product portfolio with its second deal in as many weeks.
Bausch + Lomb Continues Deal Streak With $106M Acquisition of J&J Eye Drops
